Complete mesocolic excision is currently recognized as a standard procedure for colon cancer. Controversy remains on the presence of right gastroepiploic mesentery metastasis in patients with colon cancer locating at or close to the hepatic flexure. The investigators design this study in order to define the incidence of mesogastrium metastasis and analyse the safety and surgical outcome in these patients who undergo complete mesocolic excision with right gastroepiploic mesentery resection.
Eligibility
Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria:
* Age between 18 and 75 years
* American Society of Anesthesiologists (ASA) score I to III
* A biopsy proven histological diagnosis of colorectal carcinoma
* Preoperative staging cT2-4aN0M0 or cTanyN+M0
* tumor located at hepatic flexure or transverse colon close to flexures
* Undergoing complete mesocolic excision with right gastric mesentery resection
* Patients have to be aware of the aim of the trial, and have signed the informed consent.
Exclusion Criteria:
* Synchronous colorectal carcinoma
* Clinical evidence of metastasis
* History of colorectal cancer or other malignant tumors
* Preoperative staging cT1N0 or cT4bNany
* Emergency procedure
Primary outcome measure(s)
metastasis rate — an average of 1 year the incidence of gastric mesentery metastasis
Trial sites (1)
Facility
City
Region
Status
Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.